H NMR (500 MHz) data were obtained in deuterated chloroform (CDCl 3 ) or dimethyl sulfoxide (DMSO-d6) using a Bruker DMX 500 NMR spectrometer. Column chromatography was performed using silica gel (60 Å pore size, 40-75 µm particle size) from Sorbent Technologies. Thin layer chromatography (TLC) was performed using silica gel plates (60 Å pore size, Silicycle) with UV light at 254 nm as the detection method. MALDI-MS data were collected using a Bruker Ultraflex III TOF/TOF mass spectrometer. All HPLC purifications were performed on a Varian Prostar 210 system equipped with a quaternary pump and diode array detector. All air-and moisturesensitive reactions were performed under inert atmosphere in glassware flamed under vacuum, using anhydrous dry solvents. Standard workup procedures involved multiple (~3) extractions with the indicated organic solvent, followed by washing of the combined organic extracts with water or brine, drying over Na 2 SO 4 and removal of solvents in vacuo. All yields reported were determined after purification by column chromatography or reverse phase HPLC, unless otherwise noted. All data were collected using instruments in the Chemistry Department at the University of Pennsylvania. Peptide Synthesis and Purification. FRRIAR peptide was synthesized using standard Fmoc-based solid phase peptide synthesis as described previously, 1 and then N-terminally modified with commercially available 6-azidohexanoic acid and purified by reverse-phase HPLC. 1 Alternatively, azido-FRRIAR was purchased from Anaspec as a purified white powder separated into 10 mg aliquots.
Solubilizing Linker Synthesis. 3-Azidopropionic acid was prepared from β-propiolactone by literature procedure and matched the reported 1 H NMR spectrum. 2 (4) . Sodium azide (4.5 g, 0.69 mmol, 1 eq) was dissolved in MilliQ water. β-propiolactone (4.4 mL, 0.069 mmol, 1 eq) was added dropwise and the reaction was allowed to stir at rt for 6 h. The reaction was neutralized with 1 M HCl and then extracted 3 times with diethyl ether. The organic layer was then dried over sodium sulfate and filtered through cotton. A clear oil in a 15% yield was recovered in DMSO, requiring no further purification. 
3-azidopropionic acid

FRRIAR-trisubstituted ultrasensitive cryptophane (FRRIAR-TUC) (5). After 3 h the crude reaction (3)
was then dosed with 6 μL 3-azidopropionic acid (4) (11 eq) and allowed to stir overnight while covered, to yield the FRRIAR-TUC biosensor. The reaction was diluted 10-fold in 50:50 ACN:H 2 O and purified.
Purification was achieved through reverse-phase HPLC employing a semi-preparative method and using a Grace C18 semi-preparative column (10 × 250 mm, 5 µm beads). The column was equilibrated at 90% A for 5 min. The purification method then went from 90% A to 55% A over 3 min, then from 55% A to 51% A over 7 min, and then from 51% A to 47% A over 13 min. This was followed by a gradient from 47% A to 40% A over 6 min and finally decreased to 0% A over the next min at a flow rate of 4 mL/min spectrophotometer. Percent helicity increased from 11% to 37% after FRRIAR was conjugated to cryptophane (Table S1 ).
Data Analysis. The molar ellipticity was calculated from the observed ellipticity (mdeg) and has the units of deg cm 2 dmol -1 . The molar ellipticity is given by equation S1 where C is the concentration of the peptide or biosensor, is the path length of the cuvette-0.1 cm, and is the number of residues-31. 9 [ ] = ( * * * 10)
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The helical contents of FRRIAR and FRRIAR-TUC were determined from circular dichroism studies at 30 and 10 μM concentrations, respectively, and in accordance with literature precedent. 10 The concentration variation is a result of the large difference in extinction coefficients (6970 vs 16970 M -1 • cm -1 ). Data were normalized to molar ellipticity to allow for direct comparison. Studies at various concentrations demonstrated reproducible percent helicity values (data not shown). Helicity was calculated using the formulas S2 and S3 where is the number of amino acids in the peptide, in this case 17. Racemic cryptophane was employed for these experiments, and thus did not contribute to the measured CD signal. 11 Data are shown in Table S1 . These experiments were performed in 1:1
MeOH:H 2 O because DMSO contributed to significant scattering as did the buffer to a lesser degree, Figure S9 , black stars. 8 Comparative studies between FRRIAR in buffer and FRRIAR in 1: Fluorescence spectra were collected at 25 °C in quartz cuvettes with a 1-cm path length. The samples
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were excited at 295 nm and emission data were collected from 300-400 nm. For all spectra, the slit widths were 5 nm, scan rate was 60 nm/min, averaging time was 1 s, and the data interval was 1 nm. All fluorescence studies with the biosensor (FRRIAR-TUC) and CaM were prepared in the same fashion and carried out on Cary Eclipse Fluorescence Spectrophotometer from Agilent (formally Varian).
Hyperpolarized 129 Xe NMR Spectroscopy. Hyperpolarized (hp) 129 Xe was generated using spinexchange optical pumping (SEOP) method with a home-built version of the previously commercially available Nycomed-Amersham (now GE) model IGI.Xe.2000 129 Xe hyperpolarizer. A gas mixture of 89% helium, 10% nitrogen, and 1% natural abundance xenon (Linde Group, NJ) was used as the hyperpolarizer input. 795 nm circularly polarized diode laser was used for optical pumping of Rb vapor. 129 Xe was hyperpolarized to 10-15% then cryogenically separated, accumulated, thawed, and collected in controlled atmosphere valve NMR tubes (New Era). After hp Xe collection, NMR tubes were shaken vigorously to mix cryptophane solutions with hp Xe. All 129 Xe NMR measurements were carried out on a Bruker BioDRX 500 MHz NMR spectrometer (138.12 MHz frequency for 129 Xe), using a 5-mm BBO NMR probe. Sample temperature was controlled by VT unit on NMR spectrometer to 300 ± 1 K. Eburp1
shaped pulse was used to selectively excite Xe@FRRIAR-TUC biosensor peak. Spectra were averaged over 16 scans. A delay of 0.15 s was given between scans to allow for xenon exchange. All acquired NMR spectra were processed with 25 Hz Lorentz broadening. Chemical shifts were referenced to free xenon gas of 0 atm at 0 ppm, shown in Figure 5 . The excitation bandwidth used for the selective pulse was 2000 Hz (14.5 ppm). When centered at 65 ppm, this pulse covers the chemical shift range where cryptophane and its derivatives have been previously observed. The center of the selective pulse was also varied to scan different frequency ranges, and no change in the spectrum were observed. With hard pulse excitation, the spectrum of the cage alone, apo-CaM with FRRIAR-TUC, and Holo-CaM with FRRIAR peptide only showed the Xe@aq peak. These control studies are shown in Figures 5a, S13, and S14. All NMR studies were performed in 10 mM HEPES, 1 mM CaCl 2 , pH 7.2 with 1% DMSO. measurements were converted to molar residue ellipticity values (θ) using equation S1, described above.
The fraction folded (f f ) for apo-protein was determined using linear baselines to fit the low (θ F ) and high (θ U ) temperature data, equations S4 and S5, respectively.
The entirety of the data range was then fit to equation S6 where K = e -(ΔH-TΔS)/RT , where ΔH and ΔS are adjustable parameters and R = 8.3145 J•mol -1 •K -1 . The resulting plot is shown in Figure S6 .
Where: = /(1 + ) (S6) Figure S11: Structure of tris(triazole propionic acid) cryptophane-A derivative (TTPC), a water-soluble cryptophane with good xenon affinity at rt. 13, 14 Figure S12: Xenon-129 NMR of tris(triazole propionic acid) cryptophane-A (TTPC), 70 µM. Spectrum acquired using a selective pulse centered at 61.5 ppm. A single peak, assigned to xenon encapsulated in TTPC, was observed at 64.509 ppm. Buffer: 10 mM HEPES, 1 mM CaCl 2 , pH 7.2 with 1% DMSO. 
